Increased phospholipase D activity in human breast cancer

被引:33
|
作者
Uchida, N
Okamura, S
Nagamachi, Y
Yamashita, S
机构
[1] GUNMA UNIV,SCH MED,DEPT BIOCHEM,MAEBASHI,GUMMA 371,JAPAN
[2] GUNMA UNIV,SCH MED,DEPT SURG 1,MAEBASHI,GUMMA 371,JAPAN
关键词
phospholipase D; breast tumor; phosphatidylcholine; phosphatidylethanol;
D O I
10.1007/BF01208639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phospholipase D is believed to play an important role in cell proliferation and tumorigenesis. One of its major functions is to cause a sustained activation of protein kinase C through the primary production of phosphatidic acid from phosphatidylcholine by the enzyme, followed by dephosphorylation forming diacylglycerol. Protein kinase C is known to be activated or translocated in some tumors including breast turners, In order to examine phospholipase D activity ill breast rumors, surgical specimens of human breast tumors were obtained by mastectomy or wide excision, and their phospholipase D activities were assayed by determining the formation of phosphatidylethanol from phosphatidylcholine and ethanol. Phospholipase D activity was predominantly localized in the microsomal fraction of the tumor tissue and markedly stimulated by oleic acid. We observed a significant increase in phospholipase D activity in 17 out of 19 spontaneous human breast tumors as compared to adjacent histologically normal breast tissue. The mean specific activity in the tumors was 52.9 +/- 41.8 (SD) pmol min(-1) mg protein(-1) whereas the value for the normal breast tissue was 34.0 +/- 36.2 (SD) pmol min(-1) mg protein(-1) (P < 0.01; paired Wilcoxon's rank-sum test). The mean tumor/normal activity ratio was 2.37. Among prognostic factors, the nuclear grade, evaluated according to Schnitt et al., was found to be correlated with the activity ratio. Our results suggest a role for phospholipase D in human breast tumors, An elevation in phospholipase D activity is useful as a potential marker for malignant disease in the breast.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 50 条
  • [11] Alternative phospholipase D/mTOR survival signal in human breast cancer cells
    Chen, YH
    Rodrik, V
    Foster, DA
    ONCOGENE, 2005, 24 (04) : 672 - 679
  • [12] Alternative phospholipase D/mTOR survival signal in human breast cancer cells
    Yuhong Chen
    Vanessa Rodrik
    David A Foster
    Oncogene, 2005, 24 : 672 - 679
  • [13] Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells
    Kang, Dong Woo
    Park, Mi Hee
    Lee, Young Jun
    Kim, Hyung Sik
    Lindsley, Craig W.
    Brown, H. Alex
    Min, Do Sik
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (04) : 805 - 816
  • [14] Phospholipase D activity in human gastric carcinoma
    Uchida, H
    Okamura, SI
    Kuwano, H
    ANTICANCER RESEARCH, 1999, 19 (1B) : 671 - 675
  • [15] INCREASED ANDROGENIC ACTIVITY AS AN ETIOLOGIC FACTOR OF HUMAN BREAST-CANCER
    GRATTAROLA, R
    TUMORI, 1971, 57 (04) : 279 - +
  • [16] Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer
    Manni, A
    Mauger, D
    Gimotty, P
    Badger, B
    CLINICAL CANCER RESEARCH, 1996, 2 (11) : 1901 - 1906
  • [17] Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells
    Ju Cheol Son
    Dong Woo Kang
    Kwang Mo Yang
    Kang-Yell Choi
    Tae Gen Son
    Do Sik Min
    Experimental & Molecular Medicine, 2013, 45 : e38 - e38
  • [18] Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells
    Son, Ju Cheol
    Kang, Dong Woo
    Yang, Kwang Mo
    Choi, Kang-Yell
    Son, Tae Gen
    Min, Do Sik
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2013, 45 : e38 - e38
  • [19] Increased dihydropyrimidine dehydrogenase activity in breast cancer
    Anan, K
    Mitsuyama, S
    Tamae, K
    Suehara, N
    Nishihara, K
    Ogawa, Y
    Abe, YJ
    Iwashita, T
    Toyoshima, S
    JOURNAL OF SURGICAL ONCOLOGY, 2003, 82 (03) : 174 - 179
  • [20] Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells
    Fiucci, G
    Czarny, M
    Lavie, Y
    Zhao, D
    Berse, B
    Blusztajn, JK
    Liscovitch, M
    INTERNATIONAL JOURNAL OF CANCER, 2000, 85 (06) : 882 - 888